Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

This article examines two healthcare stocks, Abbott Laboratories (ABT) and Boston Scientific (BSX), which are currently trading near their 52-week lows despite strong bullish sentiment from Wall Street analysts. Boston Scientific’s decline is attributed to litigation charges and tariff headwinds, while Abbott’s dip is linked to a significant acquisition and weakness in its Nutrition segment. The article explores why analysts remain confident in their growth prospects, highlighting product innovation and long-term sector trends.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin